Genpact (G) Names A New CFO And Launches AI Suite, Is The Stock Still Undervalued?

Genpact (G) has paired a leadership shakeup with a fresh product push. The company named Sumita Pandit as Chief Financial Officer just as it rolled out its agentic AI Record-to-Report Suite.

Genpact’s recent leadership and product announcements come against a mixed price backdrop, with the 90-day share price return up 13.35% after a weaker year-to-date share price return that declined 23.46%, while the 1-year total shareholder return fell 15.71%. This points to momentum rebuilding from a lower base.

Scan how other AI driven operators are positioned by reviewing a curated group of 74 profitable AI stocks that aren't just burning cash alongside Genpact's latest agentic push into finance operations.

Genpact is aiming to refresh its narrative with new AI products and a new CFO, while the share price continues to reflect past disappointment. Could this gap present a more favorable risk-reward balance from here?

Most Popular Narrative: 16.7% Undervalued

Genpact’s widely followed narrative pegs fair value at $42.18 per share, compared with a last close of $35.14. This frames the current discount through the lens of long-term AI and buyback themes rather than short-term price swings.

Accelerated client adoption of Genpact's Advanced Technology Solutions particularly in data and AI should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.

See why 20 investors see Genpact as 17% undervalued.

Result: Fair Value of $42.18 (UNDERVALUED)

Still, Genpact’s narrative leans on faster growing AI offerings offsetting slower legacy services, while heavier AI investment and tougher competition could pressure margins if client adoption underwhelms.

Find out about the key risks to this Genpact narrative.

Next Steps

Mixed signals on Genpact’s story so far. If you want to move quickly and shape your own view, start with the balance of 5 key rewards and 1 important warning sign.

Looking for more Genpact-sized opportunities?

Do not stop your research with Genpact. Use the Simply Wall Street Screener to surface fresh ideas that match how you like to invest and manage risk.

• Target potential mispricing by scanning a curated 32 high quality undervalued stocks that may offer more attractive entry points than the usual watchlist stocks.
• Prioritize resilience by reviewing a list of solid balance sheet and fundamentals (23 results) that can help you focus on businesses with stronger financial footing when conditions get tougher.
• Get ahead of the crowd by investigating a 15 high quality undiscovered gems before they catch wider market attention and move out of your preferred range.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com